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Background
Spondylodiscitis defines both vertebral osteomyelitis and
discitis. Two important etiologies are involved in the
pathogenesis of spondylodiscitis: Mycobacterium tuber-
culosis (TB-S) and pyogenic bacteria such as Staphylo-
coccus aureus (NTB-S). Diagnosis and treatment of
spondylodiscitis are constantly delayed because the
symptomatology is non-specific. There are controversial
opinions regarding the optimal antimicrobial therapy
duration. Aims: To overview the diagnosis and thera-
peutic difficulties in patients with spondylodiscitis.
Methods
We made a retrospective analysis of the patients with
spondylodiscitis monitored in the Third Department
of the National Institute for Infectious Diseases
“Prof. Dr. Matei Balş” between 2004 and 2014. Epide-
miological, clinical, imagistic and therapeutic data were
evaluated.
Results
Forty-three patients were analyzed with a mean age of
58.02 years old and a sex ratio M:F = 1.625:1. The etiol-
ogy analysis showed: 10 patients with TB-S (23.25%)
and 32 with NTB-S (14 with unknown etiology, 15 with
S. aureus, 2 with E. coli and 1 with Enterococcus faeca-
lis). The main location of spondylodiscitis was the lum-
bar spine (69.76%) followed by thoracic (23.25%) and
cervical spine (4.65%).
The etiological diagnosis of NTB-S was made by blood
culture – 13 patients (30.2%), culture from vertebral
abscess – 4 patients (9.3%) and from soft tissue infection –
1 patient. TB-S was confirmed by: lesion biopsy –
8 patients, PCR for Mycobacterium tuberculosis from the
CSF (1 patient who associated tuberculous meningitis)
and MRI (1 patient with multiple tuberculomas). In TB-S
patients, MRI showed a lack of disc involvement, but large
paraspinal extension. In NTB-S, MRI showed important
vertebral destruction. 23 patients had paraspinal abscess (9
with TB-S and 14 with NTB-S).
The primary infectious focus was: vertebral – 34.88%
(6 patients with TB-S without pulmonary tuberculosis and
9 patients after neurosurgery for spinal disc herniation),
skin and soft tissue infection – 11.62%, endocarditis – 1
patient, diverticulitis – 1 patient, urinary tract infection –
2 patients and unknown - 37.2%. The mean duration of
NTB-S antimicrobial therapy was 4.74 months (between
one month for patients who had neurosurgical therapy
and 20 months for a patient with extensive lesions who
did not benefit by neurosurgery). The access to neurosur-
gery was limited: only 11 patients were operated – 6 with
TB-S and 5 with NTB-S.
Conclusion
A limited number of patients have access to neurosur-
gery in Romania and as a consequence, a prolonged
antimicrobial therapy is necessary. In the current con-
text when Clostridium difficile infection represents a
real threat, it is important to make a major change in
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